US Patent 9181298 Intermediates for macrocyclic compounds
Patent 9181298 was granted and assigned to Ocera Therapeutics on November, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+161 characters)
Article
Patent abstract
The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates:
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09181298 Intermediates for macrocyclic compounds US Patent 9181298 Intermediates for macrocyclic compounds
Infobox
Patent Number
0918129800
Patent Number
918129800
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091812980
Date of Patent
November 10, 2015
0Patent Application Number
122736380
Date Filed
November 19, 2008
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091812980
Date of Patent
November 10, 2015
0Patent Application Number
122736380
Date Filed
November 19, 2008
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09181298 Intermediates for macrocyclic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09181298
Date of patent
November 10, 2015
Patent application number
12273638
Date Filed
November 19, 2008
Patent primary examiner
Find more entities like US Patent 9181298 Intermediates for macrocyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.